Dermatomyositis and polymyositis (myositis) trials in India

3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  Where

  Ahmedabad, Bangalore, Dehradun, Delhi, Gurugram, Hyderabad, Kolkata, Lucknow, Mumbai, Mysuru, New Delhi, Puducherry, Secunderabad

  Age

  18 years to 75 years

  People

  240 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06455449
• Phase 3Taking people
  A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  Where

  Gurugram (Gurgaon), Kochi, Kolkata

  Age

  18 years and over

  People

  318 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05895786 · EU 2022-502739-20-00
• Phase 3Taking people
  A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

  Where

  Ernākulam, Gurugram

  Age

  18 years and over

  People

  211 worldwide

  Run by

  Pfizer

  See details and how to joinNCT06698796 · EU 2024-514648-10-00